CTSO News and Press, CytoSorbents Corporation From 05/13/25

2025-05-13 18:48:10 ET Cytosorbents Corporation (CTSO) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.70%. The average open to low on the day of earnings was -7.56%. The average open ...

2025-05-13 18:43:09 ET Cytosorbents Corporation (CTSO) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CTSO stock price following earnings has averaged ±4.63% , with a median of 1.97%....

2025-05-13 17:35:39 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript Cytosorbents outlines 2025 growth strategy with $1B market potential for DrugSorb-ATR Seeking Alpha’s Quant Rating on Cytosorbents Historical e...

CytoSorbents Provides Regulatory Update for DrugSorb-ATR PR Newswire PRINCETON, N.J. , May 1, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care uni...

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights PR Newswire PRINCETON, N.J. , April 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in th...

2025-04-21 08:10:50 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript Cytosorbents outlines 2025 growth strategy with $1B market potential for DrugSorb-ATR Seeking Alpha’s Quant Rating on Cytosorbents Historical e...

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program PR Newswire PRINCETON, N.J. , April 21, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threaten...

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller PR Newswire Ms. Grossman brings 25 years of accomplished finance and accounting experience in global, publicly-traded companies Company announces Inducement Grant Under Nasdaq L...

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America PR Newswire PRINCETON, N.J. , April 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the int...

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants PR Newswire PRINCETON, N.J. , April 4, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care...